Trip to immunity: Resistant cytomegalovirus infection in a lung transplant recipient

International Journal of Infectious Diseases

Volumn 28, Issue , 2014, Pages 140-142

  Kneidinger, Nikolaus ^a   Giessen, Clemens ^a   vonWulffen, Werner ^a   Milger, Katrin ^a   Schramm, René ^a   Jäger, Gundula ^a   Nitschko, Hans ^a   Striebinger, Hannah ^a   Behr, Jürgen ^a   Neurohr, Claus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cytomegalovirus; Ganciclovir resistance; Immune monitoring; Leflunomide; Transplantation

Indexed keywords

FOSCARNET; GAMMA INTERFERON; GANCICLOVIR; IMMUNOGLOBULIN; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; VALGANCICLOVIR; ANTIVIRUS AGENT; CYTOMEGALOVIRUS-SPECIFIC HYPERIMMUNE GLOBULIN; ISOXAZOLE DERIVATIVE;

ABSENCE OF SIDE EFFECTS; ADAPTIVE IMMUNITY; ADULT; ANTIVIRAL RESISTANCE; ANTIVIRAL THERAPY; ARTICLE; CASE REPORT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPERIMENTAL THERAPY; FEMALE; FEVER; GENERALIZED EDEMA; GRAFT RECIPIENT; HUMAN; HYPOKALEMIA; HYPOMAGNESEMIA; IMMUNOSUPPRESSIVE TREATMENT; INTERFERON GAMMA RELEASE ASSAY; KIDNEY DYSFUNCTION; LOADING DRUG DOSE; LOSS OF APPETITE; LUNG TRANSPLANTATION; NAUSEA; NONHUMAN; POINT MUTATION; POSTOPERATIVE PERIOD; SIDE EFFECT; VIRUS LOAD; WEIGHT GAIN; CYTOMEGALOVIRUS INFECTIONS; IMMUNOLOGICAL MONITORING; IMMUNOLOGY;

ADULT; ANTIVIRAL AGENTS; CYTOMEGALOVIRUS INFECTIONS; DRUG RESISTANCE, VIRAL; FEMALE; FOSCARNET; GANCICLOVIR; HUMANS; IMMUNOGLOBULINS; ISOXAZOLES; LUNG TRANSPLANTATION; MONITORING, IMMUNOLOGIC; TRANSPLANT RECIPIENTS;

EID: 84949116386     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.06.009     Document Type: Article

References (5)

1. Lurain N.S., Chou S. Antiviral drug resistance of human cytomegalovirus. Clin Microbiol Rev 2010, 23:689-712.
2. Sester M., Sester U., Gärtner B., Heine G., Girndt M., Mueller-Lantzsch N., et al. Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation. Transplantation 2001, 71:1287-1294.
3. Humar A., Mazzulli T., Moussa G., Razonable R.R., Paya C.V., Pescovitz M.D., et al. Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients. Am J Transplant 2005, 5:1065-1070.
4. Waldman W.J., Knight D.A., Blinder L., Shen J., Lurain N.S., Miller D.M., et al. Inhibition of cytomegalovirus in vitro and in vivo by the experimental immunosuppressive agent leflunomide. Intervirology 1999, 42:412-418.
5. Verkaik N.J., Hoek R.A., van Bergeijk H., van Hal P.T., Schipper M.E., Pas S.D., et al. Leflunomide as part of the treatment for multidrug-resistant cytomegalovirus disease after lung transplantation: case report and review of the literature. Transpl Infect Dis 2013, 15:243-249.